Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: A systemic review and meta-analysis.

Zihao Guo, Jiali Jiang, Hao Wu, Jinxia Zhu, Shutian Zhang, Chuan Zhang

Medicine 2021 Aug 13

filter terms:

A rapid lateral flow test (Peptest) to detect pepsin in saliva/sputum has been considered as a valuable method for diagnosing laryngopharyngeal reflux (LPR) and gastroesophageal reflux disease (GERD). The aim of this meta-analysis is to analyze the utility of Peptest for diagnosis of LPR and GERD. PubMed, EMBASE, and the Cochran Library (from January 1980 to 26 January 2020) were searched for pepsin in saliva for LPR/GERD diagnosis. Sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, and area under the curve data were summarized to examine the accuracy. A total of 16 articles that included 2401 patients and 897 controls were analyzed. The pooled sensitivity and specificity for the diagnosis of GERD/LPR with Peptest were 62% (95% confidence interval [CI] 49%-73%) and 74% (95% CI 50%-90%), respectively. The summarized diagnostic odds ratio and area under the curve were 5.0 (95% CI 2-19) and 0.70 (95% CI 0.66-0.74), respectively. Peptest shows moderate diagnostic value for LPR and GERD. More studies with standard protocols should be done to verify its usefulness. Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Citation

Zihao Guo, Jiali Jiang, Hao Wu, Jinxia Zhu, Shutian Zhang, Chuan Zhang. Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: A systemic review and meta-analysis. Medicine. 2021 Aug 13;100(32):e26756